People Background Check
Find People:

James T Tamura, Age 65Happy Valley, OR

Get Report
Known as:
James Tadashi Tamura James G Tamura Jim Tamura

James Tamura Phones & Addresses

Gresham, OR

Portland, OR

Beaverton, OR

San Diego, CA

Vista, CA

Gresham, OR

El Cajon, CA

Bakersfield, CA

Des Moines, IA

Show more

Mentions for James T Tamura

James Tamura resumes & CV records

Resumes

James Tamura Photo 18

General Manager

Location:
Gresham, OR
Industry:
Import And Export
Work:
Dowson Technology LLC since Feb 2013
General Manager DOWSON LLC Mar 2010 - Feb 2013
VP Operations/Marketing Asset Management & Sales, LLC Jan 2009 - Feb 2010
Event Manager
Education:
Pierce College 1977 - 1980
Management and Fashion Merchandise, Business, Fashion, Economics,
Skills:
Marketing Strategy, New Business Development, Business Strategy, Business Development, Sales Management, Strategic Planning, Product Development, Market Research, Start Ups, Lead Generation, B2B, Marketing
James Tamura Photo 19

Owner

Industry:
Real Estate
Work:
Structural Termite Diagnostics
Owner
James Tamura Photo 20

James Tamura

James Tamura Photo 21

Owner, Dowson Llc

Position:
Owner at DOWSON LLC
Location:
Portland, Oregon Area
Industry:
Import and Export
Work:
DOWSON LLC
Owner
James Tamura Photo 22

Owner, J&J Pacific Imports Llc

Location:
Portland, Oregon Area
Industry:
Import and Export

Publications & IP owners

Us Patents

Methods Of Treating Immune Diseases By Administering Antibody Polypeptides That Antagonize Cd40

US Patent:
2020019, Jun 25, 2020
Filed:
Dec 20, 2019
Appl. No.:
16/723047
Inventors:
- Princeton NJ, US
- Brentford, GB
Suzanne SUCHARD - Portland OR, US
Aaron YAMNIUK - Lawrenceville NJ, US
Stanley KRYSTEK - Ringoes NJ, US
James TAMURA - Yardley PA, US
James BRYSON - Langhorne PA, US
Steven GRANT - Swaffham Prior, GB
Philip DREW - Histon, GB
International Classification:
C07K 16/28
A61K 39/395
A61K 45/06
C07K 16/18
Abstract:
Antibody polypeptides that specifically bind a novel epitope of human CD40 are provided. The antibody polypeptides do not exhibit CD40 agonist activity. The antibody polypeptides are useful in the treatment of diseases involving CD40 activation, such as autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single Vor Vdomain. The half-life of the antibody polypeptides may be increased by modifying the antibody polypeptides to be dual specific reagents that can also bind human serum albumin (HSA).

Possible Relatives

Kevin P Tamura  Paul M Tamura  Robert H Tamura  Ronald P Tamura  Bruce Tamura  James M Last  James G Stanco  James A Stanczak  James B Standifer  James F Standiford 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.